An official opening of this state-of-the-art laboratory is planned for May 20, 2015.

The expansion has seen the previous 1,393 square meter laboratory space more than double in size to 3,400 square meters, and once validation is completed, the laboratory will act as a dedicated cGMP pharmaceutical testing site.

The workforce has increased from 65 to 115, with the potential for up to another 40 employees in the additional facilities.

Investment at the laboratory has been focused on increasing stability chamber capacity, and in supporting chromatography equipment, including new UPLC capabilities.

The Mumbai facility now has the largest stability testing facility in the SGS Life Science Services' global network, with the expansion driven by the increased demand from both local and international customers.

The Mumbai expansion follows SGS's renovation of its Chennai, India, laboratory in 2014, increasing laboratory space within the facility.

The number of employees increased from 60 to 75, with the flexibility to further accomodate up to 90.

"India is strategically very important for SGS Life Science Services, and the investments we have made in both Mumbai and Chennai have been based on customer demand for dedicated Full Time Equivalent-based models," commented Mr Paul House, MD, SGS India. "These two facilities, coupled with our facility in Singapore, work very much as a harmonized unit, supporting not only local clients but those across Southeast Asia and beyond."